⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1823973 | 0.75 | GRM5 (0.34) | — | |
| SCHEMBL16095982 | 0.72 | — | — | |
| SCHEMBL1069178 | 0.72 | PARP1 (0.36) | — | |
| SCHEMBL6599221 | 0.69 | TDP1 (0.31) | — | |
| SCHEMBL9598366 | 0.67 | ADORA2B (0.37) | — | |
| SCHEMBL21295269 | 0.64 | LTA4H (0.38) | — | |
| SCHEMBL17962407 | 0.63 | MEN1 (0.44) | — | |
| SCHEMBL2013280 | 0.63 | CLK4 (0.41) | — | |
| SCHEMBL22399895 | 0.62 | DDB1 (0.42) | — | |
| SCHEMBL5547790 | 0.62 | BRD4 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1385833-A1 | TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS | Amgen Inc. (US) | 2004-02-04 | — | — | EP | disclosed |
| WO-2002083654-A1 | TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS | AMGEN INC. (US) | 2002-10-24 | — | — | WO | disclosed |